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The viral accessory protein Vpx, expressedby certain
simian and human immunodeficiency viruses (SIVs
and HIVs), is thought to improve viral infectivity of
myeloid cells. We infected 35 Asian macaques
and African green monkeys with viruses that do or
do not express Vpx and examined viral targeting of
cells in vivo. While lack of Vpx expression affected
viral dynamics in vivo, with decreased viral loads
and infection of CD4+ T cells, Vpx expression had
no detectable effect on infectivity of myeloid cells.
Moreover, viral DNA was observed only within
myeloid cells in tissues not massively depleted of
CD4+ T cells. Myeloid cells containing viral DNA also
showed evidence of T cell phagocytosis in vivo, sug-
gesting that their viral DNA may be attributed to
phagocytosis of SIV-infected T cells. These data sug-
gest that myeloid cells are not a major source of SIV
in vivo, irrespective of Vpx expression.
INTRODUCTION
Human immunodeficiency viruses (HIVs) and simian immuno-
deficiency viruses (SIVs) infect humans and nonhuman pri-
mates and these viruses persist for the life of the host. The
ability of HIV and SIV to maintain life-long infections is thought
to depend on the ability of these viruses to latently infect long-
lived cells in vivo (Katlama et al., 2013). Therefore, understand-
ing which cells are targeted by the virus is of critical
importance, as the life span of individual cells infected by the
virus will dictate the longevity of latent infection within the
host. The cells reported to be targeted by HIV and SIV in vivo
are CD4+ T cells and myeloid cells (Alexaki et al., 2008). Neither
CD4+ T cells nor myeloid cells represent a homogeneous pool
of target cells. Instead, individual subsets of CD4+ T cells and
myeloid cells are thought to be differentially infected by the
virus in vivo.ImAmong CD4+ T cells, three large populations exist: naive CD4+
T cells, memory CD4+ T cells, and terminally differentiated mem-
ory CD4+ T cells (Brenchley et al., 2004a). While all three subsets
are infected by the virus in vivo, they do not populate all anatom-
ical sites equally (Brenchley et al., 2004b) and are not equally
infected (Brenchley et al., 2004a), with memory CD4+ T cells
residing within the gastrointestinal (GI) tract infected most
frequently (Brenchley et al., 2004b;Mattapallil et al., 2005).Mem-
ory CD4+ T cells are thought to live for decades (Combadiere
et al., 2004) and thus represent a very long-lived population of
target cells for the virus. Myeloid cells have also been suggested
to be an important target cell population for HIV/SIV (Hirsch et al.,
1998; Igarashi et al., 2001; Koppensteiner et al., 2012; Orenstein
et al., 1997) and although there has been some debate related to
their longevity, it is generally thought their half life is approxi-
mately 1–2months (Gonzalez-Mejia and Doseff, 2009; van Furth,
1989), with the possible exception of brain microglia cells (Greter
and Merad, 2013). However, recent findings that macrophages
are capable of proliferation in vivo suggest that tissue macro-
phages may, indeed, have a more limited life span (Jenkins
et al., 2011; Robbins et al., 2013).
In fact, one factor that influences the ability of the virus to infect
individual cells is the proliferative capacity of the target cells.
Indeed, cells that are actively dividing aremore prone to infection
in vivo than resting cells (Alexaki et al., 2008). One explanation for
limited infectivity of resting cells, compared to activated and
dividing cells, is low intracellular concentrations of nucleotides
within resting cells (Goldstone et al., 2011). In resting cells, nucle-
otides are hydrolyzed by the host protein SAM domain and
HD domain-containing protein 1 (SAMHD1) (Goldstone et al.,
2011). The activity of SAMHD1 is thought to involve its phosphor-
ylation and is active in resting CD4+ T cells andmyeloid cells, and
its expression and activity are thought to limit infection of these
cells by HIV/SIV (Baldauf et al., 2012; Laguette et al., 2011).
Recent studies have implicated viral protein x (Vpx), a viral
accessory protein expressed by some strains of SIV and
by HIV-2, in binding to SAMHD1, leading to its proteasomal
degradation (Laguette et al., 2011). HIV-2 and SIVs used to
experimentally infect Asian macaques originate from SIVsmm,
which is a virus that naturally infects sootymangabeys inwesternmunity 41, 493–502, September 18, 2014 ª2014 Elsevier Inc. 493
Table 1. Study Animal Characteristics
Animal Virus Species
CD4+
T Cellsa Viral Loadb
Disease
State
MGE mac239 RM 283 7.3 3 104 acute
K7M mac239 RM 188 2.4 3 106 acute
K8Y mac239 RM 1,855 8.4 3 107 acute
A8E084 mac239 RM 513 1.1 3 106 acute
DB4E mac239 RM 565 8.1 3 105 chronic
DB07 mac239 RM 317 5.5 3 105 chronic
DCXX mac239 RM 439 1.5 3 106 chronic
PSP mac239 RM 194 7.8 3 106 sAIDS
CF5T mac239 RM 216 8.0 3 105 sAIDS
CE5D mac239 RM 532 1.2 3 105 sAIDS
DB17 mac239 RM 122 9.2 3 104 sAIDS
CF4J mac239 RM 241 2.0 3 105 sAIDS
KMO mac239DVpx RM 803 1.7 3 102 acute
EV3 mac239DVpx RM 1,312 3.2 3 102 acute
EMJ mac239DVpx RM 280 7.8 3 102 acute
4364 mac239DVpx RM 426 9.2 3 102 acute
591 e543 RM 186 2.5 3 105 chronic
760 e543 RM 296 5.0 3 103 chronic
759 e543 RM 526 6.0 3 102 chronic
827 e543 RM 69 3.7 3 105 sAIDS
833 e543 RM 133 1.5 3 105 sAIDS
DBPX e660 RM 304 undetected chronic
98P030 mac239 PTM 178 7.2 3 103 chronic
99P029 mac239 PTM 8 5.4 3 106 chronic
99P030 mac239 PTM 29 3.7 3 104 sAIDS
A1P012 mac239 PTM 5 4.2 3 105 sAIDS
A0P007 mac239 PTM 30 4.9 3 104 sAIDS
98P005 mac239 PTM 33 7.6 3 103 sAIDS
99P052 mac239 PTM 30 6.4 3 105 sAIDS
A0P039 mac239 PTM 45 1.9 3 104 sAIDS
AG17 agm AGM 235 9.7 3 104 chronic
AG24 agm AGM 128 1.1 3 104 chronic
AG5 agm AGM 251 undetected chronic
AG10 agm AGM 212 5.4 3 104 chronic
AG12 agm AGM 252 4.0 3 102 chronic
aNumber of CD4+ T cells/ml of blood.
bCopies of viral RNA/ml of plasma.
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Vpx Expression and Viral DNA in MacrophagesAfrica and expresses the viral accessory protein Vpx. HIV-1 and
other immunodeficiency lentiviruses, like SIVagm, do not ex-
press Vpx (Fregoso et al., 2013). Given the differential expression
of Vpx by HIVs and SIVs, one prediction might be that these
viruses differ in their proclivity to infect resting CD4+ T cells
and myeloid cells in vivo. Here we have examined tissue cellular
sources for SIV using Asian macaques and African green mon-
keys infected with different strains of the virus expressing or
lacking Vpx. We found viral DNA within myeloid cells only in
anatomical sites that were not severely CD4+ T cell depleted,
that Vpx expression had little (if any) effect on our ability to detect
viral DNA within myeloid cells, and that myeloid cells that con-
tained viral DNA also had evidence of T cell phagocytosis in vivo.494 Immunity 41, 493–502, September 18, 2014 ª2014 Elsevier Inc.RESULTS
Animals and Anatomical Sites Studied
To investigate cellular sources for primate immunodeficiency
viruses, we isolated lymphocytes from liver, spleen, small intes-
tine, large intestine, mesenteric lymph nodes, and bron-
cheoalveolar lavage (BAL) using tissues taken at necropsy
from SIV-infected Asian macaques (both rhesus and pigtail)
and SIV-infected African green monkeys (AGMs) (35 animals to-
tal). These animals were sacrificed at different time points rela-
tive to SIV infection, ranging from the acute phase of infection
to end-stage simian AIDS. As such, the animals had diverse
CD4+ T cell counts and plasma viral loads (Table 1). This diverse
cohort of SIV-infected animals provided an ideal opportunity to
examine cellular targets for viral replication at different stages
of disease. Moreover, the different viral inoculum allowed for
examination of Vpx-mediated effects of cellular targeting.
Memory CD4+ T Cells and Myeloid Cells Express
SAMHD1
Given that the viral accessory protein Vpx was recently shown
to degrade the host restriction factor SAMHD1 (Laguette et al.,
2011), we initially studied expression of SAMHD1 in subsets of
lymphocytes thought to be targeted by HIV and SIV in vivo. Using
flow cytometric sorting, we isolated naive CD4+ T cells, CD28+
andCD28memoryCD4+T cells, andmonocytes fromperipheral
blood of six SIV-uninfected rhesusmacaques and examined rela-
tive expression of SAMHD1 mRNA by quantitative RT-PCR (Fig-
ure 1A). We found that naive CD4+ T cells expressed very low
amounts of SAMHD1 mRNA. Meanwhile, CD28+ memory CD4+
T cells expressed higher amounts of SAMHD1 mRNA than
CD28 memory CD4+ T cells (p = 0.031), and peripheral blood
monocytes expressed SAMHD1 at similar amounts to CD28+
memoryCD4+ T cells. Thus, we anticipated anyVpx-mediated ef-
fects on SAMHD1 to be observed predominantly in myeloid cells
andCD28+memoryCD4+Tcells. Toconfirm that the transcription
of SAMHD1 was not affected by the proinflammatory state of the
immune system observed in progressive SIV infection, we sorted
the same subsets of lymphocytes from peripheral blood of six
chronically SIVmac239-infected rhesus macaques. Expression
of SAMHD1messagewas found to be equivalent across lympho-
cyte subsets irrespective of SIV infection status (Figure 1B) as
confirmedbyRT-PCRand immunoblotting (Figure1C).Moreover,
theproteindid not appear tobephosphorylatedbyanyof thecells
we studied in vivo (Figure 1C). It was therefore possible to
examine the proclivity of viruses with and without Vpx to infect
different cellular targets. We hypothesized that viruses encoding
Vpx would infect CD28+ memory CD4+ T cells and myeloid cells
more efficiently than viruses without Vpx.
Myeloid Cells Contain Little, If Any, Viral DNA in
Mucosal Sites
Given that mucosal sites have been shown to be massively
depleted of CD4+ T cells during the acute phase of infection
and throughout the chronic phase of infection (Brenchley
et al., 2004b; Mattapallil et al., 2005; Picker et al., 2004; Veazey
et al., 1998), we hypothesized that without preferred CD4+ T cell
targets, viruses expressing Vpx would more efficiently infect
myeloid cells at mucosal sites. Therefore, we flow cytometrically
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Figure 1. Memory CD4+ T Cells and Myeloid
Cells Express SAMHD1
(A and B) SAMHD1 mRNA in naive CD4+ T cells,
CD28+ memory CD4+ T cells, CD28 memory
CD4+ T cells, and myeloid cells in peripheral blood
of SIV-uninfected (A) and SIV-infected (B) rhesus
macaques. Expression relative to b-actin mRNA.
(C) Total and phosphorylated SAMHD1 protein in
naive CD4+ T cells, CD28+ memory CD4+ T cells,
CD28 memory CD4+ T cells, and myeloid cells in
peripheral blood of SIV-uninfected animals. 40 mg
of primary cell extract or 20 mg of THP-1 cell extract
were separated by SDS-PAGE and immunoblotted
using antibodies against SAMHD1, phosphory-
lated SAMHD1, or b-actin. Horizontal lines indicate
the median. Immunoblots are representative of
three experiments.
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Vpx Expression and Viral DNA in Macrophagessorted the few memory CD28+, CD28 memory CD4+ T cells
when possible andmyeloid cells from small intestine, large intes-
tine, liver, and BAL of SIV-infected Asian macaques (Figure 2).
The myeloid cells were sorted so as to include all myeloid cell
types, including macrophages, monocytes, and the various sub-
sets of dendritic cells (gating strategy in Figure S1 available on-
line). Each subset of CD4+ T cells was not equally abundant at
each anatomical site. For example, naive CD4+ T cells and differ-
entiated CD28 memory CD4+ T cells were not abundant in the
liver or within the GI tract (Figures 2A–2C). Therefore, we were
unable to sort sufficient numbers of cells corresponding to
eachCD4+ T cell subset. However, it was possible to amplify viral
DNA from CD28+ memory CD4+ T cells from all four mucosal
sites of every animal we examined. Moreover, we successfully
amplified viral DNA from naive CD4+ T cells from the small and
large intestines of approximately 50% of the animals. There
were very low frequencies of naive CD4+ T cells in the liver of
all animals, but we were able to obtain sufficient numbers of liver
naive CD4+ T cells from two animals in our cohorts to amplify viral
DNA. Although we successfully amplified viral DNA from even
small numbers of CD28+ memory CD4+ T cells (on average
only 2,000 cells) sorted from GI tract, liver, and BAL samples,
we found viral DNA in myeloid cells from the GI tracts of only
two animals. The frequencies of CD4+ T cells in the intestines
of these animals (99P029 for small intestine and 759 for large
intestine) were 10.3% and 36.6%, respectively. Therefore the
GI tracts of these animals contained ample CD4+ T cell targets.
There were only 5 copies of viral DNA in GI tract myeloid cells
of 759, and 15 copies of viral DNA in GI tract myeloid cells of
99P029. We found no viral DNA in myeloid cells from the BAL
or liver, despite having been able to flow cytometrically sort
abundant numbers of myeloid cells (more than twomillion cumu-
latively) from both liver and BAL.Immunity 41, 493–502, SeMyeloid Cells Can Contain Viral
DNA in Lymphoid Tissues
After finding remarkably low amounts
of viral DNA within myeloid cells from
mucosal tissues, we next examined infec-
tion frequencies of the same cellular sub-
sets within spleen and mesenteric lymph
nodes (mLNs) where viral replication islikely more rampant in chronically SIV-infected animals. Consis-
tent with our findings from mucosal tissues, the CD28+ memory
CD4+ T cells weremore frequently infected than any other subset
in both rhesus and pigtail macaques, irrespective of which virus
lineage was chosen to infect (Figures 3A and 3B). However,
unlike our findings within the GI tract, myeloid cells within the
mLNs and spleen of SIV-infected Asian macaques frequently
contained viral DNA. In particular, K8Y demonstrated the highest
amounts of viral DNA within splenic myeloid cells, after sacrifice
during peak viral replication at day 10 after SIV infection.
Given that Asian macaques infected with viruses encoding
Vpx had myeloid cells containing viral DNA in the spleen and
mLNs, we next sought to examine the infection frequencies of
cell subsets of animals infected with viruses that do not express
Vpx. We flow cytometrically sorted naive CD4+ T cells, CD28+
memory CD4+ T cells, and myeloid cells frommLNs and spleens
of five chronically SIVagm-infected AGMs. Similar to our findings
in SIV-infected Asian macaques, we found that CD28+ memory
CD4+ T cells of the spleen and mLNs were more frequently
infected than any other cellular subset (Figures 3C and 3D).
Furthermore, viral DNA was detected in myeloid cells from the
spleen and mLNs from two of five AGMs (40%) (Figures 3C
and 3D). These data suggest that expression of Vpx by SIV did
not allow the virus to infect myeloid cells more efficiently in vivo.
Indeed, exactly the same percentage of Asian macaques (40%)
had viral DNA within splenic and mLN myeloid cells when the
infecting viruses expressed Vpx (Figures 3A and 3B).
Myeloid Cells Can Contain Viral DNA without Viral
Expression of Vpx
Recent studies have proposed an evolutionary relationship
shared by host restriction factors and viral proteins Vpx and
Vpr (Fregoso et al., 2013), suggesting that our finding of viralptember 18, 2014 ª2014 Elsevier Inc. 495
A B
C D
Figure 2. Myeloid Cells Contain Little, If
Any, SIV DNA in Mucosal Sites
Copies of viral DNA/100 naive CD4+ T cells, CD28+
memory CD4+ T cells, CD28 memory CD4+
T cells, and myeloid cells in SIV-infected Asian
macaques (A) small intestine, (B) large intestine,
(C) liver, and (D) BAL. See also Figure S1.
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Vpx Expression and Viral DNA in MacrophagesDNA in myeloid cells of SIVagm-infected AGMs (Figures 3C
and 3D) might be attributed to Vpr-mediated degradation of
SAMHD1 since SIVagm expresses Vpr. Therefore we examined
the infection frequencies of cellular targets in animals acutely in-
fected with a virus genetically manipulated to delete Vpx (Berger
et al., 2012). Animals infected with SIVmac239DVpx clearly man-
ifested lower cellular infection (Figure 4) and correspondingly low
plasma viral loads (Table 1).
As revealed by our studies of infected cell subsets in lymphoid
tissue, acutely SIV-infected animals had the highest amount of
viral DNA within myeloid cells in spleen. Therefore, to investigate
whether the high frequency of infected myeloid cells was medi-
ated by expression of Vpx by SIVmac239, we infected four ani-
mals with SIVmac239DVpx and sacrificed them during acute
infection. We then flow cytometrically sorted the different cell
subsets from the spleen and measured viral DNA concentration
(Figure 4). While the amount of viral DNA was considerably lower
in the animals acutely SIVmac239DVpx-infected compared
to animals acutely SIV-infected with wild-type SIVmac239, we
amplified viral DNA from myeloid cells of all acutely infected an-
imals. To determine whether there was a decreased tendency to
detect SIVmac239DVpx within myeloid cells compared to CD4+
T cells, we measured the ratio of viral DNA in CD28+ memory
CD4+ T cells to the level of viral DNA in myeloid cells in animals
acutely infected with SIVmac239DVpx or SIVmac239 (Figure 4).
We found that these ratios completely overlapped among ani-
mals infected SIVs with or without Vpx (p = 0.46). From these
data, it seems unlikely that Vpx was facilitating infection of
myeloid cells in vivo. These data suggested to us either that
the viral DNA found within myeloid cells may not be attributed496 Immunity 41, 493–502, September 18, 2014 ª2014 Elsevier Inc.to bone fide viral infection in vivo or that
other viral adaptations are necessary to
render myeloid cells susceptible to pro-
ductive infection.
Myeloid Cells Phagocytose T Cells
In Vivo
Given the predominant assumption that
macrophage tropism develops as a result
of CD4+ T cell target loss, we were some-
what surprised to find viral DNA only in
myeloid cells from tissues in which CD4+
T cells were more abundant (spleen and
mLN) (Figure 5A). Moreover, the quanti-
ties of viral DNA found in myeloid
populations directly correlated with the
frequencies of viral DNA+CD4+ T cells in
the same anatomical sites (Figure 5B).
This finding suggested that one potential
explanation for the viral DNA found inmyeloid cells was impure flow cytometric sorting. Indeed,
myeloid cells are notoriously difficult to sort purely (Heeregrave
et al., 2009). Therefore we performed a post-sort analysis of
myeloid cells isolated from the spleens of several animals where
the myeloid cells were found to contain viral DNA (Figure S2).
While the post-sort purity of myeloid cells was consistently
lower than that of CD4+ T cell subsets (data not shown), the
number of contaminating memory CD28+ CD4+ T cells was
too low to account for all of the viral DNA found within sorted
myeloid cells.
A third explanation for viral DNAwithin myeloid cells is myeloid
cell-mediated phagocytosis of SIV-infected CD4+ T cells.
Indeed, phagocytosis of apoptotic and necrotic cells is a well-
established function of tissue macrophages, especially in the
spleen (Wynn et al., 2013). Specifically, we quantified TCR gd
DNA because these loci are rearranged during early T cell
development and as a result, many circulating mature T cells
express rearranged, but nonfunctional, gd genes (Spits, 2002).
To confirm that our PCR would detect T cell-specific DNA, we
also flow cytometrically sorted T cells, B cells, natural killer
(NK) cells, and monocytes from peripheral blood of five SIV-
uninfected animals. We found between 0.5 and 2 copies of
rearranged TCR DNA in T cells, but there was very little, if any,
rearranged TCR DNA in B cells, NK cells, or monocytes (Fig-
ure 5C). We then confirmed that this PCR assay could be used
to measure phagocytosis of T cells by coculturing peripheral
blood monocytes (with very little rearranged TCR DNA) (Fig-
ure 5C), with irradiated autologous, CFSE-labeled T cells or irra-
diated, CFSE-labeled J-LAT cells. We then flow cytometrically
sorted monocytes from these cocultures every day after the
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Figure 3. Myeloid Cells Can Contain SIV
DNA in Lymphoid Tissues
Copies of viral DNA/100 naive CD4+ T cells, CD28+
memory CD4+ T cells, CD28 memory CD4+
T cells, and myeloid cells in SIV-infected Asian
macaques (A) spleen or (B) mLN or in SIVagm-in-
fected African greenmonkey (C) spleen or (D)mLN.
Immunity
Vpx Expression and Viral DNA in Macrophagescoculture until the monocytes began to die (5 days after cocul-
ture). We then measured the amount of rearranged TCR DNA
in the monocytes that had been cocultured. We found that rear-
ranged TCR DNA in monocytes peaked at 2–4 days after cocul-
ture and then began to decrease (representative data from four
experiments, Figure 5D).
Having shown that rearranged TCR DNA within myeloid cells
could be used as a proxy of T cell phagocytosis, we next sought
to investigate phagocytosis of T cells in vivo. We measured the
amount of rearranged DNA coding for the T cell receptor within
myeloid cells from different anatomical sites (Figure 5E). The
number of copies of rearranged TCR DNA in tissue myeloid
populations varied widely among animals within the same site
and among tissues, particularly at the GI tract and spleen,
where variation approached three orders of magnitude (Fig-
ure 5E). Thus rearranged TCR DNA was not detected in all
tissue myeloid cells equally. To confirm the identity of the rear-
ranged TCR DNA amplified from myeloid cells, we cloned and
sequenced the TCR DNA amplified from myeloid cell lysate
of two animals, CF4J and AG17. All clone sequences were
confirmed to encode rearranged gd TCR (Table 2). The clones
were not homogeneous, with significant sequence diversity
evident (Table 2). These data strongly suggest that the TCR
DNA amplified from myeloid cells could not be attributed to
germline TCR DNA and that myeloid cells are phagocytosing
T cells in vivo. The number of rearranged TCR copies detected
in tissue myeloid cells positively correlated with the quantity of
viral DNA measured within the same cells (Figure 5F, r = 0.66,
p = 0.004).Immunity 41, 493–502, SeConsidering that myeloid cells are
notoriously difficult to isolate from tissues
and to identify by flow cytometry, we
also isolated myeloid cells from paraffin-
embedded tissue by immunohisto-
chemical staining for myeloid cells and
performing laser capture microdissection
(LCM) using laser cutting to isolate indi-
vidual myeloid cells from different tissues.
We isolated myeloid cells from the spleen
of three SIV-infected animals and from the
colon of four SIV-infected animals and
measured the amount of rearranged
TCR and viral DNA (Figure 5G). We were
able to amplify both viral DNA and rear-
ranged TCR DNA from all LCM samples
and the amounts were within the ranges
found when we had isolated the cells
by flow cytometry (Figure 5G). Taken
together, these data suggest that the viral
DNA found within myeloid cells couldeasily be attributed to phagocytosis of SIV-infected CD4+
T cells in vivo.
DISCUSSION
Here we have sampled mucosal and lymphoid tissues from SIV-
infected Asianmacaques and African greenmonkeys to examine
the cellular sources for SIV based upon differential expression of
Vpx. We found that (1) CD28+ memory CD4+ T cells were most
frequently viral DNA+ compared to any other cellular target in
all anatomical sites, (2) myeloid cells within mucosal tissues
very rarely contained viral DNA, (3) myeloid cells in the spleen
or mLNs of 40% of animals contained viral DNA, (4) myeloid cells
could contain viral DNA irrespective of viral Vpx expression, (5)
myeloid cells phagocytosed T cells in vivo, and (6) viral DNA
within myeloid cells was associated with phagotycosis of
T cells. Consequently, it was not possible to identify bona fide
SIV infection of myeloid cells from any anatomical site of our
animals.
Understanding the cellular substrates for HIV/SIV replication
in vivo is of importance for developing therapeutic interventions
aimed at decreasing the size of the HIV/SIV reservoir (Katlama
et al., 2013; Siliciano and Siliciano, 2013). It is fairly well accepted
that the half-life of latent reservoirs in HIV/SIV-infected individ-
uals treated with ARVs is longer than the individual’s lifespan
(Finzi et al., 1999). Therefore, ARV regimens that fully suppress
viral replication will be insufficient to cure HIV-infected individ-
uals of the infection (Finzi et al., 1999; Katlama et al., 2013; Sili-
ciano and Siliciano, 2013). Given that significant research effortptember 18, 2014 ª2014 Elsevier Inc. 497
Figure 4. Myeloid Cells Can Contain Viral DNA without Viral Expres-
sion of Vpx by SIV
Copies of viral DNA/100 naive CD4+ T cells, CD28+ memory CD4+ T cells,
CD28 memory CD4+ T cells, and myeloid cells in spleen of acutely SIV-
mac239-infected and acutely SIVmac239DVpx-infected Asian macaques (left
four columns). Ratio of viral DNAwithin CD28+memory CD4+ T cells compared
to viral DNA within myeloid cells (right column).
Immunity
Vpx Expression and Viral DNA in Macrophagesstrives to develop therapeutic interventions aimed at stimulating
HIV from the latent pool, understanding which cells are infected
by the virus is critical (Margolis, 2011).
It is widely accepted that the largest pool of HIV/SIV-infected
cells belong to the CD4+ T cell subset, and our data are
completely consistent with this supposition. However, another
pool of leukocytes posited to be an important source of HIV/
SIV-infected cells is myeloid cells, and especially tissue macro-
phages (Dai et al., 2013; Koenig et al., 1986; Smith et al., 2003;
Wang et al., 2001). Consistent with these previous studies, we
also found viral DNA within myeloid cells. There are several ex-
planations to account for the finding of viral DNA or RNA within
tissue myeloid cells of HIV/SIV-infected individuals. While a pop-
ular explanation revolves around bona fide infection of myeloid
cells by the virus in vivo, the functional nature of this subset of
cells provides for alternative explanations. Myeloid cells, and tis-
sue macrophages in particular, are charged with clearing immu-
nological complexes and phagocytosing dead and dying cells
in vivo. During infection, there are high levels of antibodies that
bind to the virus and high levels of infected CD4+ T cells, which
become necrotic or apoptotic. This suggests that myeloid cells
may accumulate viral RNA and viral DNA by the normal clear-
ance functions they have evolved to perform.
Given several recent studies that suggest expression of the
accessory protein Vpx by HIV-2 or SIV facilitates viral infectivity
of myeloid cells in vitro (Berger et al., 2011; Hrecka et al., 2011;
Laguette et al., 2011; Pauls et al., 2013), we used nonhuman pri-
mates infected with SIVs either expressing Vpx or lacking Vpx
and examined the corresponding amounts of viral DNA within in-
dividual subsets of lymphocytes. While viruses that expressed
functional Vpx clearly infected CD4+ T cells more efficiently
than Vpx-deleted viruses, with correspondingly higher plasma
viral loads, Vpx expression had nomeaningful effect on the pres-
ence of viral DNA found within myeloid cells. Our findings are
consistent with very recent data suggesting that Vpx expression
is insufficient to overcome SAMHD1-mediated HIV-1 restriction498 Immunity 41, 493–502, September 18, 2014 ª2014 Elsevier Inc.among dendritic cells (Bloch et al., 2014). Similarly, Vpx may be
insufficient to overcome SAMHD1 in tissue myeloid cells.
Other studies would posit that viruses could evolve toward a
macrophage tropism when CD4+ T cell substrates are massively
depleted. Indeed, experimental depletion of CD4+ T cells in SIV-
infected animals with anti-CD4 antibodies leads to enhanced
viral replication within myeloid cells (Ortiz et al., 2011). Moreover,
chimeric HIV/SIV viruses that cause rapid and profound deple-
tion of CD4+ T cells might lead to emergence of macrophage
tropic viruses (Igarashi et al., 2003). Our animal cohort consisted
of 8 animals with less than 50 CD4+ T cells/ml blood (2 animals
had less than 10 CD4+ T cells/ml). Even in these animals, myeloid
cells containing viral DNA also contained rearranged TCR DNA,
and myeloid cells contained viral DNA only in tissues that were
not dramatically CD4+ T cell depleted. Hence the viral replication
attributed to myeloid cells, which almost inevitably immediately
precedes death in profoundly CD4+ T cell-depleted animals,
may in fact be attributed to myeloid cell clearance mechanisms.
Moreover, even in these animals with incredibly low numbers of
peripheral blood CD4+ T cells, CD4+ T cell numbers in lymphoid
tissue were not nearly as low. Notably, despite having only 5
CD4+ T cells/ml of blood, A1P012 had a CD4+ T cell frequency
of 43.9% in mLNs, and 39% of these were memory CD4+ T cells.
Our analysis of myeloid cell viral infectivity was by no means
comprehensive. HIV/SIV infection of microglia cells in the brain
is widely believed to play an important role in virus-associated
neurological disorders (Burdo et al., 2010; Dang et al., 2012;
Gonzalez-Perez et al., 2012; Koenig et al., 1986; Koppensteiner
et al., 2012; Thompson et al., 2011). Unfortunately, flow cytomet-
ric isolation of lymphoid and myeloid cells from the brain is
extremely challenging and we were unable to perform quantita-
tive PCR for viral DNA from brain-resident cell subsets. Hence
the immunological clearance mechanisms that seem to underlie
viral DNA within GI tract and lymphoid tissue myeloid cells may
or may not also occur within myeloid cells of the nervous system
and/or other anatomical sites. Moreover, myeloid cells in
different anatomical sites are incredibly functionally and pheno-
typically heterogeneous, and future studies may elaborate
whether myeloid cells without phagocytic function contain viral
DNA and rearranged TCR DNA.
In addition tomyeloid cells, SAMHD1 has also been suggested
to restrict HIV/SIV infection of resting CD4+ T cells (Baldauf et al.,
2012; Descours et al., 2012). Our data are consistent with viral
expression of Vpx leading to enhanced infectivity of resting
memory CD4+ T cells given the increased frequencies of viral
DNA in CD28+ memory CD4+ T cells sorted from animals in-
fected with Vpx-expressing viruses relative to animals infected
with Vpx viruses. This strongly suggests that Vpx has a func-
tional role in vivo, consistent with recent data demonstrating
significantly lower viral loads and delayed progression to simian
AIDS in animals infected with Vpx-deleted viruses (Westmore-
land et al., 2014). Moreover, the fact that we routinely found viral
DNA only in myeloid cells in anatomical sites not massively
depleted of CD4+ T cells could suggest that CD4+ T cell/myeloid
cell interactions are required for myeloid cell infectivity or that
myeloid cells might become SIV infected during phagocytosis
of CD4+ T cells. Further work is certainly merited to determine
whether myeloid cells in lymphoid tissues contain replication-
competent SIV. However, we believe our data clearly suggest
A B
C D
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Figure 5. Tissue Myeloid Cells Phagocytose
T Cells
(A) Frequencies of CD4+ T cells in the small bowel
(SB), large bowel (LB), liver, broncheoalveolar
lavage (BAL), spleen, and mesenteric lymph nodes
(mLNs) from our cohort of SIV-infected animals.
(B) Correlation between the amount of viral DNA in
CD4+ T cells and the amount of viral DNA inmyeloid
cells.
(C) Amount of rearranged TCR DNA in peripheral
blood T cells, B cells, NK cells, and monocytes
from uninfected rhesus macaques.
(D) Amount of rearranged TCR DNA in monocytes
at indicated time points after coculture with irradi-
ated autologous primary T cells (black) or J-Lat
cells (green).
(E) Amount of rearranged TCR DNA in myeloid cells
from anatomical sites.
(F) Correlation between the amount of viral DNA in
myeloid cells and the amount of rearranged TCR
DNA in myeloid cells.
(G) Amount of rearranged TCR DNA (left columns)
or SIV DNA (right column) in myeloid cells isolated
by flow cytometry (open symbols) or laser cutting
(closed symbols).
Horizontal lines indicate the median. See also
Figure S2.
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clearance of virally infected cells and immune complexes and
not bone fide SIV infection of myeloid cells in vivo.
In summary, our findings suggest that the frequencies of
myeloid cells that contain viral DNA within certain anatomical
sites of SIV-infected animals are not influenced by viral expres-
sion of Vpx. Rather, viral DNA within myeloid cells in the tissues
we studied may be attributed to phagocytosis of infected CD4+
T cells. This finding, in turn, strongly suggests that myeloid cells
may not represent a significant source of infected cells in vivo
and that therapeutic interventions aimed at stimulating latent
virus should target CD4+ T cells.Immunity 41, 493–502, SEXPERIMENTAL PROCEDURES
Subjects
To characterize and determine the cellular targets
for SIV in vivo, we studied tissues from a diverse
cohort of SIVagm-infected African green monkeys
and SIV-uninfected and -infected RM and PTM.
Tissues were obtained at necropsy from 22 rhesus
macaques (Macaca mulatta), 8 pigtail macaques
(Macaca nemestrina), and 5 African green monkeys
(Chlorocebus pygerythrus) at a variety of times
after infection with SIVmac239, SIVmac239DVpx,
SIVsmE543, or SIVagm. Animals with simian AIDS
were diagnosed by opportunistic infections, lym-
phomas, or greater than 15% body mass weight
loss. Animals were housed and cared in accor-
dance with American Association for Accreditation
of Laboratory Animal Care standards in AAALAC-
accredited facilities, and all animal procedures
were performed according to the protocol
LMM12 approved by the Institutional Animal Care
and Use Committees of the National Institute of
Allergy and Infectious Diseases (Table 1). Mono-
cytes and lymphocytes from five healthy humanswere obtained by the NIH blood bank. The subjects all gave informed consent
in compliance with the NIH institutional review board.
Flow Cytometry
The SIV infection frequency of naive, CD28+ memory, and CD28 memory
CD4+ T cells and myeloid cells was determined by flow cytometrically sorting
each subset. Naive CD4+ T cells were defined as live, CD45+CD3+CD4+
CD28+CD95 lymphocytes; CD28+ memory CD4+ T cells were defined
as live, CD45+CD3+CD4+CD28+CD95+ lymphocytes; CD28 memory CD4+
T cells were defined as live, CD45+CD3+CD4+CD28CD95+/ lymphocytes;
myeloid cells were defined as live, CD45+CD3CD20NKG2AHLA-DR+.
Cells were then stained with the live dead exclusion dye Aqua blue (Invitrogen),
then with antibodies to CD3 (clone SP34-2, BD Pharmingen), CD4 (clone L200,
BD Pharmingen), CD95 (clone DX2, BD Pharmingen), CD28 (clone CD28.2,eptember 18, 2014 ª2014 Elsevier Inc. 499
Table 2. Rearranged TCR DNA Sequences in Myeloid Cells
TCR VG9 Sequences
-VLFHCQRVSPQ
CCSTA-KEFLVI
CCSTAKEFPIMH
CCSTAKEFPS-H
CVVPLPKSF-PH
CVVPLPKSFLY-
CVVPLPKSFSPH
CVVPLPKSFSPH
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Vpx Expression and Viral DNA in MacrophagesBeckman Coulter), CD8 (clone SK8, BD Pharmingen), NKG2A (clone Z199
Beckman Coulter), CD20 (clone BD Pharmingen), HLADR (clone BD Pharmin-
gen), CD14 (clone BD Pharmingen), and CD45 (clone BD Pharmingen).
Immunohistochemistry and Laser Cutting Microdissection of
Myeloid Cells
Immunohistochemistry for myeloid cells was performed on spleen and colon
sections (7 mm) mounted on PEN membrane frame (MMI) slides using a
biotin-free polymer approach (Golden Bridge International). Slides were dew-
axed and rehydrated with double-distilled H2O and antigen retrieval was per-
formed by heating sections in boiling (100C–102C) 10 mM sodium citrate
(pH 6.0) for 15 min followed by placing immediately in ddH2O. Nonspecific
Ig-binding sites were blocked with blocking buffer (TBS containing 0.05%
Tween-20 and 0.25% casein) for 10 min at room temperature. Slides were
incubated with a cocktail of myeloid/macrophage specific antibodies including
CD163 (1:400; Novocastra), CD68 (1:400; Biocare), and HAM56 (1:400; DAKO)
diluted in blocking buffer and incubated for 60min at room temperature. Slides
were washed in 13 TBS with 0.05% Tween-20 and were developed with
Mouse Polink-2 AP according to manufacturer’s recommendations, washed,
and incubated with Warp Red chromagen (Biocare Medical). The slides
were washed in ddH2O and air-dried prior to laser capture microdisection
(LCM) utilizing a laser cutting approach. We determined that the optimal laser
settings for LCM for colon and spleen tissue in order to prevent potential dam-
age to the myeloid cell DNA was 0.5% transmission, UV cutting speed 91, UV
cut length 400 mm. The cutting areawas centered on the nucleus of the cell and
the size was 16 mm (14 to 18 mm) determined by the size and configuration of
eachmyeloid cell selected. Captured cells (250 from each tissue) on LCM caps
were placed in a GeneAmp tube (Applied Biosystems, N8010611) that con-
tained 50 ml of Proteinase K solution (Acturus Picopure DNA Extraction Kit,
Applied Biosystems). Each tube was inverted to allow total immersion of the
tissue in the proteinase solution and incubated at 65C for 20 hr. The samples
were then stored at 20C and the total lysate used for DNA PCR analysis.
DVpx Virus
SIVmac239DVpx was created by splice overlap extension PCR as described
(Gibbs et al., 1995). In brief, two PCRproductswere amplified fromSIVmac239
plasmid DNA by using Herculase II Fusion DNA Polymerases (Agilent Technol-
ogies) with the following pairs of primers: BstBF (50-GGAGAGGCCTTCG
AATGGCTAAACAG-30) and DvpxR (50-CCTGCCCCATGTTACTATTCATCATG
CCAGTAT-30), or DvpxF (50- ATACTGGCATGATGAATAGTAACATGGGGCA
GG-30) and AfeR (50-CATGAAGAGCGCTCGTTGGAGGATTC-30 ). Reaction
conditions were as follows: 95C for 2 min, followed by 30 cycles at 95C for
20 s, 60C for 20 s, and 72C for 30 s, followed by 72C for 2 min. A second
round PCR was performed using the mixture of these two PCR products as
template and the primers BstBF and AfeR with the same reaction conditions.
These reactions generated a product containing a truncated SIVmac239 Vpx
region in which nt 6,245–6,346 were deleted and replaced by two stop codons,
TAGTAA (nucleotide numbers are based on the sequence of SIVmac239,
GenBank accession M33262). The full-length SIVmac239DVpx plasmid was
constructed by subcloning of this PCR product into wild-type SIVmac239
plasmid with restriction sites BstbI and AfeI and sequenced using an Applied
Biosystems 3130XL genetic analyzer. Virus stockwas obtained by transfection
of 293T cells and titrated on TZM-bl cells as previously described (Wu et al.,
2012).500 Immunity 41, 493–502, September 18, 2014 ª2014 Elsevier Inc.Cell-Associated SIV DNA Quantification
Cell subsets were sorted using a FACS Aria II using FACSDiva software (BD
Pharmingen). Sorted cells were then lysed using 25 ml of a 1:100 dilution of
proteinase K (Roche) in 10 mM Tris buffer. Quantitative PCR was performed
using 5 ml of cell lysates per reaction. Reaction conditions were as follows:
95C holding stage for 5 min, and 50 cycles of 95C for 15 s followed by
60C for 1 min using the Taq DNA polymerase kit (Invitrogen). For SIVmac239,
the sequence of the forward primer is 50-GTCTGCGTCATYTGGTGCATTC-30,
the reverse primer sequence is 50-CACTAGYTGTCTCTGCACTATRTGTTTTG-
30, and the probe sequence is 50-CTTCRTCAGTYTGTTTCACTTTCTCTTCT
GCG-30. For SIVsmE543, the sequence of the forward primer is 50-GGCAGG
AAAATCCCTAGCAG-30, the reverse primer sequence is GCCCTTACTGCCTT
CACTCA-30, and the probe sequence is 50-AGTCCCTGTTCRGGCGCCAA-30.
For SIVagm, the sequence of the forward primer is 50-GTCTGCGTCAT(T/C)TG
GTGCATTC-30, the reverse primer sequence is 50-CACTAG(C/T)TGTC
TCTGCACTAT(A/G)TGTTTTG-30, and the probe sequence is 50-CTTC(A/G)
TCAGT(C/T)TGTTTCACTTTCTCTTCTGCG-30. For cell number quantitation,
monkey albumin was measured as previously described (Mattapallil et al.,
2005). The PCR machine used for all real-time PCR was the StepOne Plus
(Applied Biosystems) and the analysis was performed using StepOne software
(Applied Biosystems).
Real-Time PCR Analysis of SAMHD1 Expression
Cell subsets were sorted as described above and extracted using TRI reagent
(Sigma-Aldrich). Extracted total RNA was retrotranscribed using SuperScript
III reverse transcriptase following the manufacturer’s instructions (Invitrogen).
Oligonucleotide primers used were as follows: for SAMHD1, forward (50-
GCTGCTGAAGAACATCCGAG-30) and reverse (50-GAGAGGGTGGAGCTCA
ATGT-30); for ACTB, forward (50-ATTGCCGACAGGATGCAGAA-30) and
reverse (50-GCTGATCCACATCTGCTGGAA-30). Quantitative real-time PCR
was performed using Power SYBR Green Master Mix (Invitrogen) at the
following conditions: 95C holding stage for 10 min, followed by 45 cycles at
94C for 30 s, 58C for 45 s, and 72C for 30 s. Relative expression was calcu-
lated using the DCt method.
Immunoblots
Cell extracts were prepared using IP Lysis Buffer (Pierce) according to the
manufacturer’s instructions. Protein concentration was determined using
BioRad Protein Assay Reagent (BioRad). Protein extracts were treated with
Laemlii buffer with beta-mercaptoethanol and resolved on a 4%–12%NuPage
Bis-Tris gel (Invitrogen). Proteins were transferred by electro-blotting onto an
Invitrolon PVDF membrane (Invitrogen), blocked with PBS with 0.1% Tween-
20 5% BSA, and incubated overnight with primary antibody (rabbit anti-
SAMHD1 fromProtein Tech, mouse anti-b-actin clone ACI4 fromSigma, rabbit
anti-phospho-SAMHD1 clone T592 was kindly provided by M. Benkirane)
(Cribier et al., 2013). Membranes were then washed and incubated with appro-
priate HRP-conjugated detector antibodies, then washed and signal detected
using Novex ECL HRP reagent (Invitrogen).
In Vitro Phagocytosis Assay
Autologous lymphocytes or J-LAT cells were irradiated with 3,000 rads. Ten
million irradiated lymphocytes or irradiated J-LAT cells were labeled with
0.25 mM CFSE and were mixed with ten million monocytes. Monocytes were
flow cytometrically sorted daily after coculture and levels of rearranged TCR
DNA was determined by qPCR.
Rearranged TCR DNA Quantification
Cells were sorted and lysed as described above. Quantitative real-time TCR
PCR was performed. Reaction conditions were as follows: 95C holding stage
for 7 min, followed by 45 cycles at 95C for 45 s, 60C for 1 min, and 72C for
90 s. Rearranged TCRG DNA detection was accomplished using a proprietary
mix of unlabeled primers (Invivoscribe), AmpliTaq Gold Polymerase (Applied
Biosystems), and SYBR Green dye (Invitrogen) (Yao and Schneider, 2007).
TCRG Cloning and Sequence Analysis
TCR PCR product was purified by gel electrophoresis using a QIAquick gel
extraction kit (QIAGEN) and cloned into the pCR4-TOPO vector (Invitrogen).
Plasmid was purified using a QIAprep Spin Miniprep kit (QIAGEN) and
Immunity
Vpx Expression and Viral DNA in Macrophagessequenced by Eurofins MWG (Operon). Sequence analysis was performed
using Gene Codes Sequencher v.5.1.
Plasma Viral Loads
Plasma samples were analyzed for SIV RNA using a fluorescent resonance en-
ergy transfer probe-based real-time RT-PCR (TaqMan) assay that provides a
threshold sensitivity of 10 copy Eq/ml, as previously described (Cline et al.,
2005). All PCR reactions were run on ABI Prism 7700 Sequence Detection Sys-
tem and the fluorescent signal-based quantitation of viral RNA copy numbers
in test samples was determined by ABI sequence detection software (Applied
Biosystems).
Statistical analysis was performed using GraphPad Prism v.5 using the
Mann-Whitney t test.
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